RSVP
ABBV icon

Ramsay Stattman Vela & Price’s AbbVie ABBV Stock Holding History

Ramsay Stattman Vela & Price’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-7,550
Closed -$312K – 51
2013
Q2 		$312K Buy
+7,550
New +$330K 0.19% 46

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ramsay Stattman Vela & Price's ABBV Position: Q3 2013 in Review

Ramsay Stattman Vela & Price sold out of AbbVie (ABBV) in Q3 2013, closing a stake of 7,550 shares — an estimated $312K sold.

Ramsay Stattman Vela & Price first reported a position in ABBV in Q2 2013 and held it in 1 quarter. The position peaked at $312K in Q2 2013. 1,296 funds tracked by Wall St. Rank hold ABBV as of Q3 2013.

  • Ramsay Stattman Vela & Price reported no remaining AbbVie position as of Q3 2013 after selling out during the quarter.
  • Ramsay Stattman Vela & Price sold 7,550 AbbVie shares in Q3 2013, an estimated $312K.
  • Ramsay Stattman Vela & Price first reported a position in AbbVie in Q2 2013 and held it in 1 quarter.
  • Ramsay Stattman Vela & Price's AbbVie position peaked at $312K in Q2 2013.
  • 1,296 funds tracked by Wall St. Rank held AbbVie as of Q3 2013.

Based on Ramsay Stattman Vela & Price's 13F filing for Q3 2013, filed 12 Nov 2013.